UK-Malaysia Partnership for Advancing Stem Cell Treatment in India

The United Kingdom-based conglomerate SRAM & MRAM Group has announced a joint venture with CELLAAX, a leading Malaysian cellular therapy biopharmaceutical company. The strategic collaboration is poised to revolutionise stem cell treatment not only in India but also across multiple regions worldwide.